The data that led an AI biotech to pick up Novo's Parkinson's stem cell therapy – Endpoints News

Australia
  1. The data that led an AI biotech to pick up Novo’s Parkinson’s stem cell therapy  Endpoints News
  2. Clinical trial finds stem cell brain transplants feasible for Parkinson’s disease  News-Medical
  3. Human embryonic stem cell-derived dopaminergic cells for Parkinson’s disease: a phase 1/2 open-label trial  Nature

Leave a Comment

Your email address will not be published. Required fields are marked *